Financials Genetec Technology

Equities

GENETEC

MYQ0104OO008

Industrial Machinery & Equipment

End-of-day quote BURSA MALAYSIA 03:30:00 01/07/2024 am IST 5-day change 1st Jan Change
2.23 MYR -0.45% Intraday chart for Genetec Technology -2.19% -5.51%

Valuation

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Capitalization 1 194 1,719 2,025 1,729 - -
Enterprise Value (EV) 1 194 1,781 1,896 1,729 1,729 1,729
P/E ratio -43.7 x 31.9 x 26.6 x 17.2 x 14.9 x 12.4 x
Yield - - - 0.89% 0.98% 1.16%
Capitalization / Revenue 2 x 7.69 x 6.59 x 4.12 x 3.57 x 3.1 x
EV / Revenue 2 x 7.69 x 6.59 x 4.12 x 3.57 x 3.1 x
EV / EBITDA - 25.6 x 23.3 x 14 x 11.8 x 9.92 x
EV / FCF - -16 x 130 x 33 x 21.1 x 16.4 x
FCF Yield - -6.27% 0.77% 3.03% 4.73% 6.1%
Price to Book - 11.5 x 5 x 3.45 x 2.87 x 2.43 x
Nbr of stocks (in thousands) 5,93,311 6,81,962 7,50,158 7,75,131 - -
Reference price 2 0.3269 2.520 2.700 2.240 2.240 2.240
Announcement Date 29/07/21 26/05/22 31/05/23 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net sales 1 97.08 223.6 307.4 419.9 484.7 557.5
EBITDA 1 - 67.2 86.87 123.9 146.3 174.3
EBIT 1 - 63.93 83.32 112.1 131.8 158.5
Operating Margin - 28.59% 27.1% 26.7% 27.19% 28.43%
Earnings before Tax (EBT) 1 - 62.29 80.3 110.5 131.3 159.5
Net income 1 - 56.4 73.4 100.2 109.1 131.3
Net margin - 25.23% 23.88% 23.86% 22.51% 23.55%
EPS 2 -0.007480 0.0790 0.1015 0.1300 0.1500 0.1800
Free Cash Flow 1 - -107.7 15.58 52.4 81.8 105.4
FCF margin - -48.19% 5.07% 12.48% 16.88% 18.91%
FCF Conversion (EBITDA) - - 17.93% 42.29% 55.91% 60.47%
FCF Conversion (Net income) - - 21.22% 52.3% 74.98% 80.27%
Dividend per Share 2 - - - 0.0200 0.0220 0.0260
Announcement Date 29/07/21 26/05/22 31/05/23 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 Q3
Net sales 1 70.47
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 16.84
Net margin 23.9%
EPS 2 2.180
Dividend per Share -
Announcement Date 28/05/24
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net Debt - 62.6 - - - -
Net Cash position - - 130 - - -
Leverage (Debt/EBITDA) - 0.932 x - - - -
Free Cash Flow 1 - -108 15.6 52.4 81.8 105
ROE (net income / shareholders' equity) - 49% 26.4% 23.2% 20.2% -
ROA (Net income/ Total Assets) - 27% 18.1% - - -
Assets 1 - 209.3 405.7 - - -
Book Value Per Share 2 - 0.2200 0.5400 0.6500 0.7800 0.9200
Cash Flow per Share - -0.1400 0.1300 - - -
Capex - 8.13 76.8 - - -
Capex / Sales - 3.64% 24.98% - - -
Announcement Date 29/07/21 26/05/22 31/05/23 - - -
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.23 MYR
Average target price
4.05 MYR
Spread / Average Target
+81.61%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GENETEC Stock
  4. Financials Genetec Technology